Oral semaglutide as effective as injectable

David Rowley 29/05/2023

obesity: overweight person holds bulge over hip

Ozempic/Wegovy sponsor trumpets results of Phase III clinical trial as its halts US ads A trial of an oral version of Novo Nordisk’s obesity and diabetes medication semaglutide, the active ingredient in high profile potential blockbuster drugs Ozempic and Wegovy, appears to deliver similar results to the incredibly popular injectable versions of the treatments. These

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

This web site is intended for Australian pharmacy professionals and is not a substitute for independent professional advice. Information and interactions contained in this website are for information purposes only and are not intended to be used to diagnose, treat, cure or prevent any disease. Further the accuracy, currency and completeness of the information available on this web site cannot be guaranteed. APPco Pty Ltd, its affiliates and their respective servants and agents do not accept any liability for any injury, loss or damage incurred by use of or reliance on the information made available via or through ajp.com.au whether arising from negligence or otherwise.

Oral semaglutide as effective as injectable

Previous ‘We don’t realise how valuable pharmacists are’

Next Research Roundup

MENU

ajp.com.au

Previous ‘We don’t realise how valuable pharmacists are’

Next Research Roundup

MENU

ajp.com.au

Tags

Hi there! 👋 Looks like you’re not logged in.